Screening for oesophageal cancer

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2009, Pages

  Yang, Shujuan ^a   Chen, Xiaoyan ^b   Shao, Ying ^a   Huang, Yuchuan ^c   Qiao, Youlin ^d   Wei, Wenqiang ^d   Yang, Jin ^a   Yang, Chunxia ^a  

^a SICHUAN UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c SICHUAN UNIVERSITY   (China)

^d INSTITUTE OF CANCER RESEARCH   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE;

CANCER MORTALITY; CANCER SCREENING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CYTOLOGY; ENDOSCOPY; ESOPHAGUS CANCER; HEALTH CARE COST; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; PATIENT COMPLIANCE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SYSTEMATIC REVIEW;

EID: 70049114407     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007883     Document Type: Review

References (47)

1. Botterweck AA, Schouten LJ, Volovics A, Dorant E, Van Den Brandt PA. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. International Journal of Epidemiology 2000;29(4):645-654 (Pubitemid 30612230)
2. Cancer Institute, Chinese Academy of Medical Sciences. Research on the early detection and treatment of esophageal cancer in high risk area. http://www.cicams.ac.cn/web/detail.aspx?nodeID=492&conID=1704 (accessed 31 December 2007).
3. Cohen J. A coefficient of agreement for nominal scales. Educational and Psychological Measurement 1960;20:37-46.
4. Coleman MP, Gatta G, Verdecchia A, Esteve J, Sant M, Storm H, et al.EUROCARE-3 summary: cancer survival in Europe at the end of th 20th century. Annals of Oncology 2003;14(Suppl 5):v128-49. (Pubitemid 46417466)
5. Corley DA, Buffler PA. Oesophageal and gastric cardia adenocarcinomas: analysis of regional variation using the Cancer incidence in Five Continents database. International Journal of Epidemiology 2001;30(6):1415-1425
6. Crane SJ, Locke GR 3rd, Harmsen WS, Zinsmeister AR, Romero Y, Talley NJ. Survival trends in patients with gastric and esophageal adenocarcinomas: a population-based study. Mayo Clinic Proceedings 2008;83(10):1087-1094
7. Dawsey SM, Fleischer DE, Wang GQ, Zhou B, Kidwell JA, Lu N, et al.Mucosal iodine staining improves endoscopic visualization of squamous dysplasia and squamous cell carcinoma of the esophagus in Linxian, China. Cancer 1998;83(2):220-231 (Pubitemid 28317800)
8. Donner A, Klar N. Issues in the meta-analysis of cluster randomized trials. Statistics in Medicine 2002;21:2971-2980
9. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical research ed.) 1997;315(7109):629-634 (Pubitemid 27387172)
10. Engel LS, Chow WH, Vaughan TL, Gammon MD, Risch HA, Stanford JL, et al.Population attributable risks of esophageal and gastric cancers. Journal of the National Cancer Institute 2003;95(18):1404-1413 (Pubitemid 37220460)
11. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer incidence, Mortality and Prevalence Worldwide (Version 2.0). Lyon: International Agency for Research on Cancer, 2004.
12. Gerson LB, Triadafilopoulos G. Screening for esophageal adenocarcinoma: an evidence-based approach. The American Journal of Medicine 2002;113(5):499-505. [MEDLINE: 12427500] (Pubitemid 35335803)
13. Guo XQ, Wang SJ, Zhang LW, Wu ML, Liu YF, Gao Y, et al.Clinical value of esophageal mucosal iodine stain during esophagoscopy for patients without swallowing symptoms. Zhonghua Zhong Liu Za Zhi [Chinese Medical Journal] 2005;27(4):238-240
14. Guo HQ, Wei WQ, Lv N, Cao J, Li ZL, Wang NP, et al.Study of Liquid-based cytology for esophageal carcinoma screening. Zhonghua Liuxingbingxue Zazhi [Chinese Journal of Epidemiology] 2008.
15. Kollarova H, Machova L, Horakova D, Janoutova G, Janout V. Epidemiology of esophageal cancer - an overview article. Biomedical Papers of The Medical Faculty of The University Palacký, Olomouc, Czechoslovakia 2007;151(1):17-20.
16. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.. Cochrane Handbook for Systematic Reviews of Interventions. 5. Wiley, 2008.
17. Descriptive Epidemiology Groups of IARC. The Globocan 2002 database, CANCER Mondial 2002. http://www-dep.iarc.fr/ (accessed 2008).
18. Ke L. Mortality and incidence trends from esophagus cancer in selected geographic areas of China circa 1970-1990. International Journal of Cancer 2002;102(3):271-274 [MEDLINE: 12397650]
19. Kouzu T, Suzuki Y, Yoshimura S, Yoshimura N, Hishikawa E, Arima M. Feature of screening-detected cancer and progress of treatment esophageal cancer. Gan to Kagaku Ryoho 1998;25(10):1499-1504
20. Lachin JM. Statistical considerations in the intent-to-treat principle. Controlled Clinical Trials 2000;21:167-189
21. Layke JC, Lopez PP. Esophageal cancer: a review and update. American Family Physician 2006;73(12):2187-2194
22. Lazarus C, Jaskiewicz K, Sumeruk RA, Nainkin J, Lazarus C, Jaskiewicz K, et al.Brush cytology technique in the detection of oesophageal carcinoma in the asymptomatic, high risk subject; a pilot survey. Cytopathology 1992;3(5):291-296
23. Lu XJ, Chen ZF, Guo CL, Li SS, Bai WL, Jin GL, et al.Endoscopic survey of esophageal cancer in a high-risk area of China. World Journal of Gastroenterology 2004;10(20):2931-2935 (Pubitemid 39303037)
24. Moschler O, Spahn TW, Middelberg-Bisping C, Grosse-Thie W, Christoph B, Kloeppel G, et al.Chromoendoscopy is a valuable tool for screening of high-risk patients with head and neck cancer for early detection of esophageal cancer. Digestion 2006;73(2-3):160-166 (Pubitemid 44155918)
25. Nabeya K, Onozawa K, Ri S. Brushing cytology with capsule for the esophageal cancer. Chirurgische Gastroenterologie 1979;13:101-107
26. National Cancer Institute. Screening statement for health professionals. Esophageal Cancer Screening (PDQ). http://www.cancer.gov/cancertopics/pdq/ screening/esophageal/HealthProfessional/page4 (accessed 4 March 2008).
27. Pan QJ, Roth MJ, Guo HQ, Kochman ML, Wang GQ, Henry M, et al.Cytologic detection of esophageal squamous cell carcinoma and its precursor lesions using balloon samplers and liquid-based cytology in asymptomatic adults in Linxian, China. Acta Cytologica 2008;52(1):14-23. [MEDLINE: 18323271] (Pubitemid 351155775)
28. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA: A Cancer Journal for Clinicians 2005;55(2):74-108.
29. Rao JNK, Scott AJ. A simple method for the analysis of clustered binary data. Biometrics 1992;48:577-585
30. Roth MJ, Liu SF, Dawsey SM, Zhou B, Copeland C, Wang GQ, et al.Cytologic detection of esophageal squamous cell carcinoma and precursor lesions using balloon and sponge samplers in asymptomatic adults in Linxian, China. Cancer 1997;80(11):2047-2059 (Pubitemid 27506017)
31. Rubenstein JH, Sonnenberg A, Davis J, McMahon L, Inadomi JM. Effect of a prior endoscopy on outcomes of esophageal adenocarcinoma among United States veterans. Gastrointestinal Endoscopy 2008;68(5):849-855 [MEDLINE: 18547567]
32. Sharma P, McQuaid K, Dent J, Fennerty MB, Sampliner R, Spechler S, et al.A critical review of the diagnosis andmanagement of Barrett's esophagus: the AGA Chicago Workshop. Gastroenterology 2004;127(1):310-330 [MEDLINE: 15236196] (Pubitemid 38962298)
33. Shen Q, Shu YJ. Cytology as a screening method for esophageal carcinoma in the People's Republic of China. In: Pfeiffer CJ editor (s). Cancer of the esophagus. Vol. 2, Boca Raton: CRC Press, 1982: 3-15.
34. Shen Q. Diagnostic cytology and early detection. In: Huang GJ, Kai WY editor(s). Carcinoma of the esophagus and gastric cardia. Berlin: Springer-Verlag, 1984:155-190
35. Shu YJ. Cytopathology of the esophagus: an overview of esophageal cytopathology in China. Acta Cytologica 1983;27(1):7-16.
36. Shu YJ. The cytopathology of esophageal carcinoma. New York: Masson, 1985.
37. Tachibana M, Kinugasa S, Shibakita M, Tonomoto Y, Hattori S, Hyakudomi R, et al.Surgical treatment of superficial esophageal cancer. Langenbecks Archives of Surgery 2006;391(4):304-321 (Pubitemid 44298420)
38. Ukoumunne OC, Gulliford MC, Chinn S, Sterne JAC, Burney PGJ. Methods for evaluating area-wide and organistation-based intervention in health and health care: a systematic review. Health Technology Assessment 1999;3(5):1-75. (Pubitemid 29201269)
39. Unnebrink K, Windeler J. Intention-to-treat: methods for dealing with missing values in clinical trials of progressively deteriorating diseases. Statistics in Medicine 2001;20:3931-3946
40. Wang GQ. 30-year experiences on early detection and treatment of esophageal cancer in high risk areas. Zhongguo Yi Xue Ke Xue Yuan Xue Bao [Chinese Medical Journal] 2001;23(1):69-72.
41. Wang GQ, Wei WQ, Lu N, Hao CQ, Lin DM, Zhang HT, et al.Significance of screening by iodine staining of endoscopic examination in the area of high incidence of esophageal carcinoma. Ai Zheng [Chinese Medical Journal] 2003;22(2):175-177
42. Wang GQ, Liu YY, Hao CQ, Lai SQ, Wang GQ, Lu N, et al.A comparative study of endoscopic image stained by iodine and histopathology in early esophageal cancer and precancerous lesions (dysplasia). Zhonghua Zhong Liu Za Zhi [Chinese Medical Journal] 2004;26(6):342-344
43. Wang GQ, Jiao GG, Chang FB, Fang WH, Song JX, Lu N, et al.Long-term results of operation for 420 patients with early squamous cell esophageal carcinoma discovered by screening. Annals of Thoracic Surgery 2004;77(5):1740-1744 (Pubitemid 38530016)
44. Wang KK, Wongkeesong M, Buttar NS. American Gastroenterological Association technical review on the role of the gastroenterologist in the management of esophageal carcinoma. Gastroenterology 2005;128(5):1471-1505 (Pubitemid 40712197)
45. Wang LD, Yang HH, Fan ZM, Lv XD, Wang JK, Liu XL, et al.Cytological screening and 15 years' follow-up (1986-2001) for early esophageal squamous cell carcinoma and precancerous lesions in a high-risk population in Anyang County, Henan Province, Northern China. Cancer Detection and Prevention 2005;29(4):317-322
46. Whitehead A, Whitehead J. A general parametric approach to the meta-analysis of randomized clinical trials. Statistics in Medicine 1991;10(11):1665-1677
47. Zhang DK, Su XD, Lin P. Survival analysis of patients with stage II squamous cell carcinoma of the thoracic esophagus after esophagectomy. Ai Zheng [Chinese Medical Journal] 2008;27(2):113-118